BRAF and cancer: Although more than 40 somatic mutations have been described in the BRAF kinase domain, the most common mutation across various cancers is the classic GTG→GAG substitution at position 1799 of exon 15, which results in the V600E amino acid change and subsequent constitutive activation of the EGFR signaling pathway.